Audentes Therapeutics Reports Second Quarter 2018 Financial Results and Provides Update on ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Patients with X-Linked Myotubular Myopathy

×

Error message

  • Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

Patients 1-3 show significant reductions in ventilator dependence, with Patient 1 achieving ventilator independence by week 24.

Metadata
Provider: 
PR NewswirePR Newswire
Retrieved on: 
Monday, February 28, 2022
Information
Tags: 
Health, Rare diseases, Centronuclear myopathy, X-linked myotubular myopathy, Myopathy, Clinical trial
Geotags: 
California, CALIFORNIA
Organisation: 
AUDENTES THERAPEUTICS, INC., DELL'ORO GROUP
Website: 
http://audentestx.com
Summary
Key Points: 
  • Patients 1-3 show significant reductions in ventilator dependence, with Patient 1 achieving ventilator independence by week 24.
  • Results from these efforts will inform clinical plans as they relate to the timing of a potential phase 1/2 clinical trial.
  • Cash Position: At June 30, 2018, Audentes had cash, cash equivalents, and short-term investments of $314.4 million.
  • At8:00 a.m. Eastern Timetoday, Audentes management will host a conference call and a simultaneous webcast to discuss its second quarter 2018 financial results and provide an update on ASPIRO, the phase 1/2 clinical trial of AT132 in Patients with X-Linked Myotubular Myopathy.


/C O R R E C T I O N -- Dell'Oro Group/

In the news release, Mobile Core Network Stagnant in 2021, Poised for Growth in 2022, According to Dell'Oro Group, issued 24-Feb-2022 by Dell'Oro Group over PR Newswire, we are advised by the company that the first paragraph, first sentence, should read "According to a recently published report from Dell'Oro Group, the trusted source for market information about the telecommunications, networks, and data center IT industries, the total Mobile Core Network (MCN) and Multi-access Edge Computing (MEC) market 2021 revenue growth slowed to the lowest rate since 2017" rather than "According to a recently published report from Dell'Oro Group, the trusted source for market information about the telecommunications, networks, and data center IT industries, the total Mobile Core Network (MCN) and Multi-access Edge Computing (MEC) market 2021 revenue growth slowed to the lowest rate since 2018" as originally issued inadvertently. And The third paragraph, last sentence should read "Not surprisingly, of the top five vendors, only Huawei and Ericsson gained overall MCN revenue market share during 2021." Instead of "Not surprisingly, of the top five vendors, only Huawei and Ericsson gained 5G MCN revenue market share during 2021." The complete, corrected release follows:

Mobile Core Network Stagnant in 2021, Poised for Growth in 2022, According to Dell'Oro Group

<span class="legendSpanClass">21 Commercial 5G SA MBB Networks Now Deployed</span>

REDWOOD CITY, Calif., Feb. 28, 2022 /PRNewswire/ -- According to a recently published report from Dell'Oro Group, the trusted source for market information about the telecommunications, networks, and data center IT industries, the total Mobile Core Network (MCN) and Multi-access Edge Computing (MEC) market 2021 revenue growth slowed to the lowest rate since 2017. The growth rate is expected to go higher in 2022 with the expansion of the 21 commercial 5G Standalone (5G SA) MBB networks that were deployed by the end of 2021, coupled with new 5G SA networks readying to launch throughout the year.

"MCN revenues for 2021 were lower than expected due to an unexpectedly poor fourth quarter performance.  The revenues for 4Q 2021 were lower than in 4Q 2020. The last time that happened was in 4Q 2017," stated Dave Bolan, Research Director at Dell'Oro Group. "The poor performance in 4Q 2021 was due to negative year-over-year revenue performance for the China region. The performance for the rest of the world was almost flat but still negative and obviously was not enough to offset the decline in China.

"The growth in 2021 came from the 5G MCN segment and was not enough to offset the decline in 4G MCN and IMS Core. Of the 21 5G SA networks commercially deployed Huawei is the packet core vendor in seven of the networks, including the three largest networks in the world located in China, and Ericsson is the packet core vendor in 10 of the networks. Not surprisingly, of the top five vendors, only Huawei and Ericsson gained overall MCN revenue market share during 2021.

"Looking at the MEC market, MEC is still a fraction of the overall MCN market, but we believe two recent announcements by Ericsson are noteworthy because, in our opinion, Ericsson will accelerate the adoption of MEC and help 5G MNOs monetize their networks by coalescing MEC implementations around the 3GPP standards. Ericsson claims to be the first to leverage recent advancements by the 3GPP standards body for edge exposure, and network slicing all the way through to a smartphone," continued Bolan.

Additional highlights from the 4Q 2021 Mobile Core Network Report:

  • Top-ranked MCN vendors based on revenue in 2021 were Huawei, Ericsson, Nokia, ZTE, and Mavenir.
  • The EMEA region was the only region to grow in revenue in 2021.
  • The APAC region was the largest region in revenue for 2021.

About the Report
The Dell'Oro Group Mobile Core Network & Multi-Access Edge Computing Quarterly Report offers complete, in-depth coverage of the market with tables covering manufacturers' revenue, shipments, and average selling prices for Evolved Packet Core, 5G Packet Core, Policy, Subscriber Data Management, and IMS Core including licenses by Non-NFV and NFV, and by geographic regions. To purchase this report, please contact us at [email protected].

About Dell'Oro Group
Dell'Oro Group is a market research firm that specializes in strategic competitive analysis in the telecommunications and enterprise networks infrastructure, network security, and data center IT markets.  Our firm provides in-depth quantitative data and qualitative analysis to facilitate critical, fact-based business decisions.  For more information, contact Dell'Oro Group at +1.650.622.9400 or visit www.delloro.com. 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/mobile-core-network-stagnant-in-2021-poised-for-growth-in-2022-according-to-delloro-group-301489305.html

SOURCE Dell'Oro Group

Copyright: 
2022 PR Newswire. All Rights Reserved.